当前位置:首页 - 行情中心 - 近岸蛋白(688137) - 财务分析 - 现金流量表

近岸蛋白

(688137)

  

流通市值:13.36亿  总市值:28.69亿
流通股本:3267.54万   总股本:7017.54万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金71,529,934.1830,084,732.4158,584,907.3117,671,708.71
  收到的税费返还101,524.1379,139.69674,111.95434,468.01
  收到其他与经营活动有关的现金4,916,686.69831,469.6633,528,952.2140,485,226.69
  经营活动现金流入小计76,548,14530,995,341.75192,787,971.46158,591,403.41
  购买商品、接受劳务支付的现金21,172,637.959,770,351.2124,276,006.821,976,627.15
  支付给职工以及为职工支付的现金54,527,389.1327,493,578.02107,669,494.2679,869,317.03
  支付的各项税费5,613,892.53,410,142.7215,946,888.4613,655,286.12
  支付其他与经营活动有关的现金9,317,677.853,596,563.2931,579,766.0523,243,742.38
  经营活动现金流出小计90,631,597.4344,270,635.24179,472,155.57138,744,972.68
  经营活动产生的现金流量净额-14,083,452.43-13,275,293.4913,315,815.8919,846,430.73
二、投资活动产生的现金流量:
  收回投资收到的现金1,260,136,651.8716,276,727.162,086,070,528.341,814,682,534.24
  取得投资收益收到的现金17,328,492.748,084,586.5516,153,525.724,844,080.34
  处置固定资产、无形资产和其他长期资产收回的现金净额70103,729.993,280
  投资活动现金流入小计1,277,465,214.54724,361,323.712,102,227,784.051,819,529,894.58
  购建固定资产、无形资产和其他长期资产支付的现金25,189,993.5613,985,374.8644,882,519.4934,641,821.82
  投资支付的现金1,099,977,414.83652,648,817.342,215,405,9801,934,360,799.45
  投资活动现金流出小计1,125,167,408.39666,634,192.22,260,288,499.491,969,002,621.27
  投资活动产生的现金流量净额152,297,806.1557,727,131.51-158,060,715.44-149,472,726.69
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--422,069.18422,069.18
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--422,069.18422,069.18
  分配股利、利润或偿付利息支付的现金--35,087,719.535,087,719.5
  支付其他与筹资活动有关的现金11,526,909.994,025,232.437,898,302.5130,529,162.16
  筹资活动现金流出小计11,526,909.994,025,232.472,986,022.0165,616,881.66
  筹资活动产生的现金流量净额-11,526,909.99-4,025,232.4-72,563,952.83-65,194,812.48
四、汇率变动对现金及现金等价物的影响-201,833.1-66,067.53616,350.04-469,541.24
五、现金及现金等价物净增加额126,485,610.6340,360,538.09-216,692,502.34-195,290,649.68
  加:期初现金及现金等价物余额646,987,827.82646,987,827.82863,680,330.16863,680,330.16
  期末现金及现金等价物余额773,473,438.45687,348,365.91646,987,827.82668,389,680.48
补充资料:
  净利润-24,223,570.82--54,416,282.1-
  资产减值准备18,127,681.15-32,094,508.76-
  固定资产和投资性房地产折旧6,340,556.04-11,364,897.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,340,556.04-11,364,897.88-
  无形资产摊销257,137.12-507,988.86-
  长期待摊费用摊销1,259,592.66-4,276,091.56-
  处置固定资产、无形资产和其他长期资产的损失-731,409.51--141,603.68-
  固定资产报废损失4,325.09-91,709.8-
  公允价值变动损失--1,804,926.16-
  财务费用-12,168,067.88--19,571,681.14-
  投资损失-267,479.91--4,569,887.11-
  递延所得税-4,622,817.58--3,284,031.83-
  其中:递延所得税资产减少-4,622,817.58--3,284,031.83-
  存货的减少-8,204,402.05--14,812,217.58-
  经营性应收项目的减少-8,429,811.99-14,644,242.81-
  经营性应付项目的增加4,547,475.22-10,757,544.87-
  其他6,212,757.08-12,629,959.55-
  现金的期末余额773,473,438.45-646,987,827.82-
  减:现金的期初余额646,987,827.82-863,680,330.16-
  现金及现金等价物的净增加额126,485,610.63--216,692,502.34-
公告日期2025-08-282025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑